Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Kidney-in-a-lymph node: A novel organogenesis assay to model human renal development and test nephron progenitor cell fates.

Francipane MG, Han B, Oxburgh L, Sims-Lucas S, Li Z, Lagasse E.

J Tissue Eng Regen Med. 2019 Sep;13(9):1724-1731. doi: 10.1002/term.2924. Epub 2019 Jul 30.

PMID:
31267702
2.

Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure.

Francipane MG, Bulanin D, Lagasse E.

Int J Mol Sci. 2019 Apr 12;20(8). pii: E1817. doi: 10.3390/ijms20081817.

3.

Towards Organs on Demand: Breakthroughs and Challenges in Models of Organogenesis.

Francipane MG, Lagasse E.

Curr Pathobiol Rep. 2016 Sep;4(3):77-85. doi: 10.1007/s40139-016-0111-9. Epub 2016 Jul 2.

4.

Regenerating a kidney in a lymph node.

Francipane MG, Lagasse E.

Pediatr Nephrol. 2016 Oct;31(10):1553-60. doi: 10.1007/s00467-015-3296-y. Epub 2015 Dec 21. Review.

5.

Therapeutic potential of mTOR inhibitors for targeting cancer stem cells.

Francipane MG, Lagasse E.

Br J Clin Pharmacol. 2016 Nov;82(5):1180-1188. doi: 10.1111/bcp.12844. Epub 2015 Dec 26. Review.

6.

Pluripotent Stem Cells to Rebuild a Kidney: The Lymph Node as a Possible Developmental Niche.

Francipane MG, Lagasse E.

Cell Transplant. 2016;25(6):1007-23. doi: 10.3727/096368915X688632. Epub 2015 Jul 8. Review.

PMID:
26160801
7.

The lymph node as a new site for kidney organogenesis.

Francipane MG, Lagasse E.

Stem Cells Transl Med. 2015 Mar;4(3):295-307. doi: 10.5966/sctm.2014-0208. Epub 2015 Feb 2.

8.

Maturation of embryonic tissues in a lymph node: a new approach for bioengineering complex organs.

Francipane MG, Lagasse E.

Organogenesis. 2014;10(3):323-31. doi: 10.1080/15476278.2014.995509. Epub 2015 Jan 7.

9.

mTOR pathway in colorectal cancer: an update.

Francipane MG, Lagasse E.

Oncotarget. 2014 Jan 15;5(1):49-66. Review.

10.
11.

Cancer Stem Cells: A Moving Target.

Francipane MG, Chandler J, Lagasse E.

Curr Pathobiol Rep. 2013 Jun 1;1(2):111-118.

12.

Management of Liver Failure: From Transplantation to Cell-Based Therapy.

Francipane MG, Cervello M, Vizzini GB, Pietrosi G, Montalto G.

Cell Med. 2011 Jun 1;2(1):9-25. doi: 10.3727/215517911X575993. eCollection 2011.

13.

Colon cancer stem cells: promise of targeted therapy.

Todaro M, Francipane MG, Medema JP, Stassi G.

Gastroenterology. 2010 Jun;138(6):2151-62. doi: 10.1053/j.gastro.2009.12.063. Review.

PMID:
20420952
14.

Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy.

Francipane MG, Eterno V, Spina V, Bini M, Scerrino G, Buscemi G, Gulotta G, Todaro M, Dieli F, De Maria R, Stassi G.

Cancer Res. 2009 Aug 1;69(15):6141-8. doi: 10.1158/0008-5472.CAN-09-0994. Epub 2009 Jul 28.

15.

Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.

Todaro M, D'Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, Dieli F, Stassi G.

J Immunol. 2009 Jun 1;182(11):7287-96. doi: 10.4049/jimmunol.0804288.

16.

Crucial role of interleukin-4 in the survival of colon cancer stem cells.

Francipane MG, Alea MP, Lombardo Y, Todaro M, Medema JP, Stassi G.

Cancer Res. 2008 Jun 1;68(11):4022-5. doi: 10.1158/0008-5472.CAN-07-6874. Review.

17.

Isolation and culture of colon cancer stem cells.

Cammareri P, Lombardo Y, Francipane MG, Bonventre S, Todaro M, Stassi G.

Methods Cell Biol. 2008;86:311-24. doi: 10.1016/S0091-679X(08)00014-9.

PMID:
18442654
18.

MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells.

Siragusa M, Zerilli M, Iovino F, Francipane MG, Lombardo Y, Ricci-Vitiani L, Di Gesù G, Todaro M, De Maria R, Stassi G.

Cancer Res. 2007 Jun 1;67(11):5522-30. Erratum in: Cancer Res. 2018 Jul 15;78(14):4101. Cancer Res. 2018 Nov 1;78(21):6344.

Supplemental Content

Loading ...
Support Center